ATE252579T1 - Tetrahydronaphthyridinyl-carboxamide mit anticonvulsiver wirkung - Google Patents

Tetrahydronaphthyridinyl-carboxamide mit anticonvulsiver wirkung

Info

Publication number
ATE252579T1
ATE252579T1 AT99957056T AT99957056T ATE252579T1 AT E252579 T1 ATE252579 T1 AT E252579T1 AT 99957056 T AT99957056 T AT 99957056T AT 99957056 T AT99957056 T AT 99957056T AT E252579 T1 ATE252579 T1 AT E252579T1
Authority
AT
Austria
Prior art keywords
tetrahydronaphthyridinyl
carboxamide
anticonvulsive effect
anticonvulsive
effect
Prior art date
Application number
AT99957056T
Other languages
English (en)
Inventor
John David Harling
Frank Peter Harrington
Mervyn Thompson
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of ATE252579T1 publication Critical patent/ATE252579T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Virology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT99957056T 1998-06-12 1999-06-09 Tetrahydronaphthyridinyl-carboxamide mit anticonvulsiver wirkung ATE252579T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9812683.2A GB9812683D0 (en) 1998-06-12 1998-06-12 Novel compounds
PCT/GB1999/001826 WO1999065903A1 (en) 1998-06-12 1999-06-09 Tetrahydronaphthyridinyl-carboxamides having anti-convulsant activity

Publications (1)

Publication Number Publication Date
ATE252579T1 true ATE252579T1 (de) 2003-11-15

Family

ID=10833636

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99957056T ATE252579T1 (de) 1998-06-12 1999-06-09 Tetrahydronaphthyridinyl-carboxamide mit anticonvulsiver wirkung

Country Status (31)

Country Link
US (2) US6410555B1 (de)
EP (1) EP1084122B1 (de)
JP (1) JP2002518390A (de)
KR (1) KR20010052792A (de)
CN (1) CN1311789A (de)
AP (1) AP2000002009A0 (de)
AR (1) AR018656A1 (de)
AT (1) ATE252579T1 (de)
AU (1) AU750470B2 (de)
BG (1) BG105126A (de)
BR (1) BR9911110A (de)
CA (1) CA2334900A1 (de)
CO (1) CO5040081A1 (de)
CZ (1) CZ293010B6 (de)
DE (1) DE69912278T2 (de)
EA (1) EA200100033A1 (de)
ES (1) ES2209524T3 (de)
GB (1) GB9812683D0 (de)
HU (1) HUP0102773A3 (de)
ID (1) ID27593A (de)
IL (1) IL140171A0 (de)
MA (1) MA26646A1 (de)
NO (1) NO20006269L (de)
NZ (1) NZ508799A (de)
PE (1) PE20000727A1 (de)
PL (1) PL344791A1 (de)
SK (1) SK18962000A3 (de)
TR (1) TR200003694T2 (de)
TW (1) TW495510B (de)
WO (1) WO1999065903A1 (de)
ZA (1) ZA200007397B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9812683D0 (en) * 1998-06-12 1998-08-12 Smithkline Beecham Plc Novel compounds
ATE228358T1 (de) * 2001-03-21 2002-12-15 Sanol Arznei Schwarz Gmbh Neue verwendung einer klasse von peptidverbindungen zur behandlung von allodynie oder andere arten von chronischen oder phantomschmerzen
EP1945639A1 (de) * 2005-11-04 2008-07-23 Pfizer Limited Tetrahydronaphthyridinderivat
WO2014036015A1 (en) * 2012-08-27 2014-03-06 Array Biopharma Inc. Serine/threonine kinase inhibitors for the treatment of hyperproliferative|diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9112721D0 (en) * 1991-06-13 1991-07-31 Smithkline Beecham Plc Novel treatment
PL330465A1 (en) * 1996-06-17 1999-05-24 Smithkline Beecham Plc Substituted benzamide derivatives and their application as anticonvulsants
GB9711257D0 (en) * 1997-05-30 1997-07-30 Smithkline Beecham Plc Novel compounds
GB9812683D0 (en) * 1998-06-12 1998-08-12 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
NZ508799A (en) 2003-08-29
BG105126A (en) 2001-11-30
CN1311789A (zh) 2001-09-05
KR20010052792A (ko) 2001-06-25
HUP0102773A2 (hu) 2002-01-28
US6410555B1 (en) 2002-06-25
NO20006269L (no) 2001-02-07
AU4280099A (en) 2000-01-05
DE69912278T2 (de) 2004-08-12
US6762192B2 (en) 2004-07-13
GB9812683D0 (en) 1998-08-12
CZ293010B6 (cs) 2004-01-14
ZA200007397B (en) 2002-02-27
WO1999065903A1 (en) 1999-12-23
ES2209524T3 (es) 2004-06-16
AR018656A1 (es) 2001-11-28
PL344791A1 (en) 2001-11-19
US20020143029A1 (en) 2002-10-03
DE69912278D1 (en) 2003-11-27
MA26646A1 (fr) 2004-12-20
BR9911110A (pt) 2001-10-30
NO20006269D0 (no) 2000-12-11
ID27593A (id) 2001-04-12
JP2002518390A (ja) 2002-06-25
IL140171A0 (en) 2002-02-10
TR200003694T2 (tr) 2001-06-21
EP1084122B1 (de) 2003-10-22
CA2334900A1 (en) 1999-12-23
SK18962000A3 (sk) 2001-08-06
EA200100033A1 (ru) 2001-06-25
HUP0102773A3 (en) 2002-09-30
EP1084122A1 (de) 2001-03-21
TW495510B (en) 2002-07-21
AU750470B2 (en) 2002-07-18
CO5040081A1 (es) 2001-05-29
AP2000002009A0 (en) 2000-12-31
PE20000727A1 (es) 2000-09-28
CZ20004611A3 (en) 2001-06-13

Similar Documents

Publication Publication Date Title
ID30132A (id) Turunan-turunan pirazol trisiklik
DK1080275T4 (da) Syntetisk græstörv
DE59910140D1 (de) Gleitschalungsfertiger
IS5699A (is) Ný notkun
ID26162A (id) Turunan-turunan benzilbifenil biosida
DE69934805D1 (de) Substituierte imidazole mit cytokin-inhibierender wirkung
DE69737411D1 (de) Induktor mit verbesserten Q-Wert
DE59708160D1 (de) 1-Dimethylaminomethyl-2-phenyl-cycloalk-2-enverbindungen mit analgetischer Wirkung
ID23287A (id) Trisiklik tersubstitusi
NO994626L (no) Substituerte benzamider
DE69908262D1 (de) Sprühbehälter
NO20010333D0 (no) Bifenylderivater
DE59901964D1 (de) Wendestangenanordnung
ID23219A (id) Trisiklik tersubstitusi
PT1135381E (pt) Mono-hidrato de hidrobrometo de eletriptano
DE59811628D1 (de) Rollenumlenkung
NO20005857D0 (no) Nye blandinger
DE69908863D1 (de) Einspritzventil
FI980759A0 (fi) Taetningskonstruktion foer suglaodan i en sugvals
NO20005435D0 (no) Bifenylderivater
ATE252579T1 (de) Tetrahydronaphthyridinyl-carboxamide mit anticonvulsiver wirkung
DE69907561D1 (de) Titanatverbindungen
ATE237615T1 (de) Tricyclische carboxamide
DE59911463D1 (de) Fahrzeugleitvorrichtung mit Fahrstreckenabtastung
DE59911610D1 (de) Substituierte benzoylcyclohexandione

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties